Johan Alm

Johan Alm

Auto-generated profile, based on publicly available information

Johan Alm

Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1999 in The Lancet
Verified
Journal Article
Closed access
JAJohan S Alm
Johan S Alm
JSJackie Swartz
Jackie Swartz
GLGunnar Lilja
Gunnar Lilja
ASAnnika Scheynius
Annika Scheynius
GPGöran Pershagen
Göran Pershagen

1 August 1997 in The Lancet
Verified
Journal Article
Closed access
JAJohan S Alm
Johan S Alm
GLGunnar Lilja
Gunnar Lilja
GPGöran Pershagen
Göran Pershagen
ASAnnika Scheynius
Annika Scheynius

1 May 2010 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IKInger Kull
Inger Kull
EMErik Melen
Erik Melen
JAJohan Alm
Johan Alm
JHJenny Hallberg
Jenny Hallberg
MSMagnus Svartengren
Magnus Svartengren
ABAnna Bergström
Anna Bergström

1 January 2006 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
HFHelen Flöistrup
Helen Flöistrup
JSJackie Swartz
Jackie Swartz
ABAnna Bergström
Anna Bergström
JAJohan S. Alm
Johan S. Alm
ASAnnika Scheynius
Annika Scheynius
TGthe PARSIFAL Study Group
the PARSIFAL Study Group

4 August 2017 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
LNLennart J. Nilsson
Lennart J. Nilsson
KBKnut Brockow
Knut Brockow
JAJohan Alm
Johan Alm
VCVictoria Cardona
Victoria Cardona
JCJean‐Christoph Caubet
Jean‐Christoph Caubet
GZGiovanna Zanoni
Giovanna Zanoni
Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non‐allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine‐triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed.

15 January 2014 in Allergy
Verified
Journal Article
Closed access
PDF file
PPP. Torregrosa Paredes
P. Torregrosa Paredes
CGC. Gutzeit
C. Gutzeit
SJS. Johansson
S. Johansson
CAC. Admyre
C. Admyre
FSF. Stenius
F. Stenius
SGSusanne Gabrielsson
Susanne Gabrielsson